H. Grunze
AuthID: R-006-ZWT
1
TÃTULO: Results of a double-blind, randomized, dose-titration, placebo controlled multicenter trial (SCO/BIA-2093-203 study) on safety and efficacy of eslicarbazepine acetate (BIA 2-093) for acute manic episodes associated with biopolar I disorder Full Text
AUTORES: Robertson, B; Grunze, H; Versavel, M; Costa, R; Almeida, L; Soares da Silva, P ;
PUBLICAÇÃO: 2010, FONTE: 4th Biennial Conference of the International-Society-for-Bipolar-Disorders in BIPOLAR DISORDERS, VOLUME: 12
AUTORES: Robertson, B; Grunze, H; Versavel, M; Costa, R; Almeida, L; Soares da Silva, P ;
PUBLICAÇÃO: 2010, FONTE: 4th Biennial Conference of the International-Society-for-Bipolar-Disorders in BIPOLAR DISORDERS, VOLUME: 12
INDEXADO EM: 
WOS
WOS